RWDD4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.387990E-02
Normal-vs-Stage2
3.741600E-01
Normal-vs-Stage3
8.141400E-01
Normal-vs-Stage4
1.460590E-01
Stage1-vs-Stage2
5.243000E-03
Stage1-vs-Stage3
2.076200E-02
Stage1-vs-Stage4
7.699000E-01
Stage2-vs-Stage3
4.970000E-01
Stage2-vs-Stage4
5.702400E-02
Stage3-vs-Stage4
1.578040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.997000E-01
Normal-vs-AfricanAmerican
3.263400E-01
Normal-vs-Asian
8.440000E-01
Caucasian-vs-AfricanAmerican
8.386600E-01
Caucasian-vs-Asian
1.829570E-01
AfricanAmerican-vs-Asian
1.887770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.055400E-01
Normal-vs-Female
4.003400E-01
Male-vs-Female
3.714600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.321150E-01
Normal-vs-Age(41-60Yrs)
3.113200E-01
Normal-vs-Age(61-80Yrs)
4.993800E-01
Normal-vs-Age(81-100Yrs)
2.012800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.414200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.500400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.637400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.440440E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.733600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.753000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.453800E-01
Normal-vs-Daily Drinker
3.542200E-01
Normal-vs-Weekly Drinker
4.854800E-01
Normal-vs-Occasional Drinker
1.515420E-01
Normal-vs-Social Drinker
4.622600E-01
Non Drinker-vs-Daily Drinker
2.409400E-01
Non Drinker-vs-Weekly Drinker
7.284200E-01
Non Drinker-vs-Occasional Drinker
3.192400E-02
Non Drinker-vs-Social Drinker
2.161400E-01
Daily Drinker-vs-Weekly Drinker
5.307400E-01
Daily Drinker-vs-Occasional Drinker
4.214400E-01
Daily Drinker-vs-Social Drinker
4.128400E-01
Weekly Drinker-vs-Occasional Drinker
1.554010E-01
Weekly Drinker-vs-Social Drinker
2.762400E-01
Occasional Drinker-vs-Social Drinker
6.318600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.169600E-01
Normal-vs-Grade 2
5.502400E-01
Normal-vs-Grade 3
1.215640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.312400E-01
Grade 1-vs-Grade 3
3.966400E-01
Grade 1-vs-Grade 4
4.169600E-01
Grade 2-vs-Grade 3
4.694600E-01
Grade 2-vs-Grade 4
5.502400E-01
Grade 3-vs-Grade 4
1.215640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.588200E-01
Normal-vs-NonDiabetic
4.314000E-01
Diabetic-vs-NonDiabetic
1.085780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.930600E-01
Normal-vs-NoPancreatitis
4.657800E-01
Pancreatitis-vs-NoPancreatitis
6.421400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.563800E-01
Normal-vs-N1
3.267200E-01
N0-vs-N1
2.361400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.791760E-01
Normal-vs-TP53-NonMutant
3.552400E-01
TP53-Mutant-vs-TP53-NonMutant
5.701000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
